Seeing Green: Balancing Safety & Compliance as Support Grows for Legal Marijuana
23 states allow recreational use of cannabis; 80% of public favors decriminalization for recreational or medical use
Schedule of Controlled Substances, established by the Controlled Substances Act of 1970 (CSA), places marijuana in the most restrictive class, Schedule I, alongside heroin. Schedule I is reserved for drugs with a high potential for abuse, no currently accepted medical uses, and a lack of accepted safety for medical use.
While de-scheduling marijuana will facilitate medical research, ensure patient access, and remove federal prohibitions, doing so will create issues for compliance, HR and risk professionals in today’s workplace — as evidenced by the challenges currently faced in states where marijuana is now legal.
23 states allow recreational use of cannabis; 80% of public favors decriminalization for recreational or medical use
Last month, Minnesota became the 23rd state to legalize recreational use of cannabis, and observers expect at least a couple ...
As the cannabis industry continues to grow, so does its demand for banking services. Brandi Reynolds champions an enhanced due ...
Risk and compliance teams are familiar with potential enforcement from federal regulators. But action from state attorneys general (acting alone ...
LOS ANGELES, Calif. (6/25/15)—A Colorado Supreme Court ruling has strengthened the ability of employers to enforce workplace drug policies, advises ...
What Business Owners Need to Know as Governments Outsource Code Enforcement Companies across virtually every industry are experiencing a rapid ...
What to Do When State and Federal Laws Disagree Nationwide, laws around marijuana are in flux, and employers struggle to ...
The federal government still prohibits banks from doing business with cannabis-based businesses, leading banks to miss out on a green ...
Founded in 2010, CCI is the web’s premier global independent news source for compliance, ethics, risk and information security.
Got a news tip? Get in touch. Want a weekly round-up in your inbox? Sign up for free. No subscription fees, no paywalls.
© 2024 Corporate Compliance Insights
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |